Safety Shot Doesn't Work — And Tastes "Nasty," According to Hunterbrook Media Unscientific Study

Based on Hunterbrook Media’s reporting, Hunterbrook Capital is short $SHOT at the time of publication. Positions may change at any time after publication. This is not investment advice. See full disclaimer below.

Imagine being able to drink as much as you want — and then, within minutes, sober up. Sounds like a dream, right? Or could it be reality? 

The beverage company Safety Shot (NASDAQ: $SHOT) has claimed its eponymous elixir can reduce blood alcohol content by up to half in 30 minutes — restoring “your central nervous system, cognition, and motor cortex.”

“My mom used to say if it’s too good to be true, it’s not true,” said Dr. Michael Fingerhood, the director of addiction medicine at Johns Hopkins Bayview Medical Center, in an interview. Given its ingredients, Safety Shot’s core selling point does not appear to be biologically possible, he said. 

Still, at Hunterbrook Media, we wanted to put Safety Shot’s claims to the test. After all, the company’s stock had been on an absolute tear, up more than 300% in the last year. And if it worked — if Safety Shot had really discovered the cure for inebriation — who knew how high its market cap could go? Monster has a market cap of $56 billion! Pepsi has a market cap of $241 billion! And those beverages can’t even help you pass a breathalyzer test!

Leave a Comment